Purchase Order 19GE5024P0046
Award Date
7/24/24
Potential Completion Date
9/30/24
Potential Value
$28K
Funding Federal Agency
Department of the Army
Contracting Federal Agency
Office of Acquisition Management
Awardee
Bio-Active Company LIMITED
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army awarded a $53,334 fixed price purchase order to Bio-Active Company LIMITED to acquire Illumina reagents in support of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. Under this contract, Bio-Active will deliver the requested genetic sequencing materials to AFRIMS between September and November 2023 to support the Institute's biomedical research efforts. No subcontractors or set aside designations were identified. The Army...
This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $102,468 contract is for preventive maintenance services on an Illumina MiSeq genetic sequencing system operated by the Naval Medical Research Unit 2 (NAMRU-2) laboratory in Cambodia. The contract has a completion date of March 7, 2020 and was awarded on March 3, 2017. No set-aside provisions were...
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
This is a firm fixed price purchase order awarded by the Department of Defense's Bureau of Medicine and Surgery to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $140,319.00 contract is for the provision of laboratory test kits and reagents to support the U.S. government's National Malaria Research Unit 2 (NMARU-2) program operating in Cambodia. No set-aside designation was used for this award. Bio-Active Company LIMITED has previously provided...
The Defense Intelligence Agency awarded a firm fixed price purchase order for $29,116 to Bio-Active Company LIMITED to provide maintenance support for one Illumina MiSeq next generation sequencing system located in Thailand. The order was issued against a blanket purchase agreement held by Bio-Active Company LIMITED to provide sequencing services and instrument sustainment to multiple U.S. agencies in Thailand, including the Department of Defense, Army Medical Command, and Centers for Disease...